Pfizer Inc | North America2Q26 First Take-20260804
| M | | | | --- | --- | --- | | Downloaded by zouguanzhong@cramc.hk | Not for redistribution without written consent of Morgan Stanley | | | | | Update | | August 4, 2026 11:39 AM GMT | | | | Pfizer Inc North America | Morgan Stanley & Co. LLC | | | | Terence C Flynn, Ph.D. | | | | Equity Analyst | | | 2Q26 First Take | Terence.Flynn@morganstanley.com Alexander Yevdokimov, Ph.D. | +1 212 761-2230 | | | Research Associate | | | | Alexander.Yevdokimov@morganstanley.com | +1 212 761-2167 | | 2Q came in ahead o ...